Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al.

Literature DB >> 33648957

Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al.

Martin Schäfer¹, Anja Strangfeld¹, Kimme L Hyrich^2,3, Loreto Carmona⁴, Milena Gianfrancesco⁵, Saskia Lawson-Tovey^2,3, Elsa F Mateus^6,7, Laure Gossec^8,9, Philip C Robinson^10,11, Jinoos Yazdany⁵, Pedro M Machado^12,13,14.

Abstract

Entities: Disease Species

Keywords: COVID-19; autoimmune diseases; epidemiology; inflammation; vaccination

Year: 2021 PMID： 33648957 DOI： 10.1136/annrheumdis-2021-220134

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study.

Authors: Naomi J Patel; Kristin M D'Silva; Tiffany Y-T Hsu; Michael DiIorio; Xiaoqing Fu; Claire Cook; Lauren Prisco; Lily Martin; Kathleen M M Vanni; Alessandra Zaccardelli; Yuqing Zhang; Jeffrey A Sparks; Zachary S Wallace
Journal: medRxiv Date: 2021-08-09

2. A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases.

Authors: Abhishek Patil; K Chanakya; Padmanabha Shenoy; S Chandrashekara; Vikram Haridas; Sharath Kumar; Manisha Daware; Ramya Janardana; Benzeeta Pinto; Ramaswamy Subramanian; S Nagaraj; Yogesh Preet Singh; Shweta Singhai; Ramesh Jois; Vikramraj Jain; C Srinivasa; B G Dharmanand; Chethana Dharmapalaiah; K N Sangeetha; Vijay K Rao; Vineeta Shobha
Journal: BMC Rheumatol Date: 2022-06-14

Review 3. Looking ahead: giant-cell arteritis in 10 years time.

Authors: Milena Bond; Alessandro Tomelleri; Frank Buttgereit; Eric L Matteson; Christian Dejaco
Journal: Ther Adv Musculoskelet Dis Date: 2022-05-24 Impact factor: 3.625

4. Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals.

Authors: Bryant R England; Punyasha Roul; Yangyuna Yang; Andre C Kalil; Kaleb Michaud; Geoffrey M Thiele; Brian C Sauer; Joshua F Baker; Ted R Mikuls
Journal: Arthritis Rheumatol Date: 2021-10-19 Impact factor: 15.483

5. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.

Authors: Daniel Clemente; Clara Udaondo; Jaime de Inocencio; Juan Carlos Nieto; Pilar Galán Del Río; Antía García Fernández; Jaime Arroyo Palomo; Javier Bachiller-Corral; Juan Carlos Lopez Robledillo; Claudia Millán Longo; Leticia Leon; Lydia Abasolo; Alina Boteanu
Journal: Pediatr Rheumatol Online J Date: 2021-11-27 Impact factor: 3.054

Review 6. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.

Authors: Christof Specker; Peer Aries; Jürgen Braun; Gerd Burmester; Rebecca Fischer-Betz; Rebecca Hasseli; Julia Holle; Bimba Franziska Hoyer; Christof Iking-Konert; Andreas Krause; Klaus Krüger; Martin Krusche; Jan Leipe; Hanns-Martin Lorenz; Frank Moosig; Rotraud Schmale-Grede; Matthias Schneider; Anja Strangfeld; Reinhard Voll; Anna Voormann; Ulf Wagner; Hendrik Schulze-Koops
Journal: Z Rheumatol Date: 2021-09-07 Impact factor: 1.372

7. TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD.

Authors: Anne Constanze Regierer; Rebecca Hasseli; Martin Schäfer; Bimba F Hoyer; Andreas Krause; Hanns-Martin Lorenz; Alexander Pfeil; Jutta Richter; Tim Schmeiser; Hendrik Schulze-Koops; Anja Strangfeld; Reinhard E Voll; Christof Specker; Ulf Mueller-Ladner
Journal: RMD Open Date: 2021-10

8. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.

Authors: Sebastian E Sattui; Richard Conway; Michael S Putman; Andrea M Seet; Milena A Gianfrancesco; Kaley Beins; Catherine Hill; David Liew; Sarah L Mackie; Puja Mehta; Lorna Neill; Gimena Gomez; Maria Isabel Haye Salinas; Federico Nicolas Maldonado; Henrique Ataide Mariz; Samia Araujo de Sousa Studart; Nafice Costa Araujo; Ann Knight; Davide Rozza; Luca Quartuccio; Maxime Samson; Stéphane Bally; Alexandre Tj Maria; Pascal Chazerain; Rebecca Hasseli; Ulf Müller-Ladner; Bimba F Hoyer; Reinhard Voll; Rita Pinheiro Torres; Mariana Luis; Sandra Lucia Euzebio Ribeirio; Samar Al-Emadi; Jeffrey A Sparks; Tiffany Y-T Hsu; Kristin M D'Silva; Naomi J Patel; Leanna Wise; Emily Gilbert; Maria Valenzuela Almada; Alí Duarte-García; Manuel Ugarte-Gil; Lindsay Jacobsohn; Zara Izadi; Anja Strangfeld; Elsa F Mateus; Kimme L Hyrich; Laure Gossec; Loreto Carmona; Saskia Lawson-Tovey; Lianne Kearsley-Fleet; Martin Schaefer; Emily Sirotich; Jonathan S Hausmann; Paul Sufka; Suleman Bhana; Jean W Liew; Rebecca Grainger; Pedro M Machado; Zachary S Wallace; Jinoos Yazdany; Philip C Robinson
Journal: Lancet Rheumatol Date: 2021-11-05

9. Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort Study.

Review 10. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].